西门子医疗：极速能谱血管造影系统在进博会实现亚洲首秀

Core Viewpoint - Siemens Healthineers has launched the ARTIS icono ceiling Xpand system at the China International Import Expo, marking a significant advancement in minimally invasive treatment for critical illnesses, particularly in the diagnosis and treatment of lung and liver cancers [1][3]. Group 1: Technological Innovations - The ARTIS icono ceiling Xpand features revolutionary 2.5-second DynaCT imaging technology, reducing imaging time by 50% compared to traditional systems, and eliminating respiratory motion artifacts, which is crucial for detecting small lesions in lung and liver cancer patients [3]. - The system introduces a world-first 0.5mm precision laser puncture navigation, enhancing the accuracy of percutaneous biopsy and ablation treatments, significantly improving detection rates while minimizing patient trauma [3][4]. - The system also incorporates AI-driven bone removal capabilities, reducing the time required for manual bone removal from 2 minutes to just 15 seconds, thus increasing operational efficiency by eight times [4]. Group 2: Strategic Collaborations - Siemens Healthineers has signed a strategic cooperation agreement with Novartis to advance the integration of radioligand therapy (RLT) and molecular imaging systems for precise diagnosis and treatment of critical illnesses like prostate cancer [4][6]. - The collaboration aims to explore future developments in integrated diagnostic and treatment systems, including optimizing payment pathways and establishing a "gold standard" for integrated treatment processes [6]. - Both companies will work on implementing pilot projects for integrated treatment centers that align with the established "gold standard" [6].